Blog - Page 4485 of 5587

ThursdayJul 10, 2008 5:47 pm

American Fiber Green Products, Inc. (AFBG.OB) is “One to Watch”

American Fiber Green Products, Inc. is focused on advancing a global environmental technology solution for the recycling of fiberglass and manufacturing alternatives to treated wood, steel and concrete products. Through fiberglass leisure products, such as boats and vintage cars, the company has a continuous business cycle of production, sales and marketing, as well as a rental program to assure shareholder value through revenue growth and profitability. Bringing together synergistic companies that will generate increased revenues and profits while rewarding shareholders, is American Fiber Green’s mission. By merging Amour Fiber Core, Inc. and American Leisure Products, Inc., the company creates a…

ThursdayJul 10, 2008 3:44 pm

Radiation Oncology Associates of New York Becomes the First to Offer Varian Medical Systems’ (VAR) RapidArc™ Radiotherapy Technology

Varian Medical Systems (VAR) is a manufacturer of medical technology for treating cancer and other medical conditions with radiotherapy, brachytherapy, and radiosurgery. The company also supplies X-ray tubes and digital image detectors for imaging in medical, scientific, and industrial applications. Its high-energy imaging systems are also used for screening cargo. Varian operates businesses in several areas: Oncology Systems, X-ray Products, and Security and Inspection Products Group. The company announced this week that, by using the company’s RapidArc™ radiotherapy technology, two prostate cancer patients - the first people in New York - were able to receive a faster, more comfortable form…

ThursdayJul 10, 2008 1:39 pm

Insmed Inc. (INSM) Shares Climb 15% on Word of Positive Bioequivalence Testing

Shares of Insmed Inc. (Nasdaq: INSM) hiked 15% to a close of 46 cents today, spurred by word the biopharmaceutical company has demonstrated the bioequivalence of INS-19, the company's recombinant human granulocyte colony stimulating factor (G-CSF). The company compared G-CSF to FDA-approved Neupogen, used to treat neutropenia, a disorder characterized by an abnormally low number of white blood cells. "These results are very exciting, as they represent Insmed's ability to replicate a protein product, to bring that product rapidly through the clinic and to demonstrate clear bioequivalence to the innovator drug," Dr. Geoffrey Allan, president and CEO of Insmed stated…

ThursdayJul 10, 2008 1:19 pm

MedeFile International Inc. (MDFI.OB) Consumer Security Is Not an Issue

MedeFile International Inc. handles highly confidential medical records and documents for the public and the healthcare industry. The nature of their business requires extreme measures to keep medical records and personal information out of the wrong hands. As a countermeasure to fight security breaches, MedeFile has implemented an online security system to ensure the safety and integrity of client data. MedeFile's security architecture ensures that its services are provided with the highest degree of privacy and integrity using well established, proven security methodologies. The architecture provides multiple lines of defense with each line employing a distinct mechanism. MedeFile's security architecture…

ThursdayJul 10, 2008 1:15 pm

DoublingStocks.com Features MyECheck Inc. (MYEC.OB)

Michael Cohen from doublingstocks.com wrote last week that MyECheck was one of the strongest penny stocks. MyECheck Incorporated is a financial electronic transaction processor and provider of alternative payment solutions for Internet and mobile commerce. Cohen chose the stock because of the rapid growth MYEC has already experienced, and the potential for continued growth in both the near and distant future. The services offered by MyECheck are very tempting to businesses seeking immediate, secure payment from their customers. Earlier this month, MyECheck was granted a patent from the United States Patent & Trademark office for their proprietary technology capable of…

ThursdayJul 10, 2008 1:10 pm

Unigene Laboratories Inc. (UGNE.OB) CEO Featured in Globally Distributed Biotechnology Publication

According to the National Osteoporosis Foundation, osteoporosis afflicts approximately 10 million Americans; approximately 34 million individuals have low bone mass, putting them at risk for osteoporosis. Unigene Laboratories Inc. (OTCBB: UGNE) is a biopharmaceutical company engaged in the oral and nasal administration of large-market peptide drugs. Recognizing the growing worldwide osteoporosis market, Unigene focuses on developing PTH-based therapies and calcitonin, a product for the treatment of postmenopausal osteoporosis. Today the company announced Warren P. Levy, Ph.D., CEO and president of Unigene, recently contributed a byline story in two leading pharmaceutical publications. The article, titled “Focusing on the Task of Reinventing…

ThursdayJul 10, 2008 11:26 am

China Medicine Corporation (CHME) is “One to Watch”

China Medicine Corp., operating in the Wholesale Trade sector and established in 2005 as Lounsberry Holdings III, Inc., is a Delaware-registered company which in 2006 acquired Guangzhou Konzern Medicine Co., Ltd as its wholly owned subsidiary, and subsequently changed its name to China Medicine Corp. Operating in the People’s Republic of China, the company distributes both licensed, prescription pharmaceuticals and over-the-counter (OTC) remedies. Their OTC remedies include Chinese herbs and traditional Chinese medications made from these herbs, as well as nutritional and dietary supplements and medical instruments. The total distribution encompasses more than 2,000 products and product lines. China Medicine…

ThursdayJul 10, 2008 10:59 am

Dutton Associates Featured Company: Pluristem Therapeutics, Inc. (PSTI)

Pluristem Therapeutics, Inc. (NASDAQ: PSTI) is a regenerative biotherapeutics corporation focused on commercializing non-personalized (allogeneic) stem cell therapy products for the treatment of severe degenerative, malignant, and autoimmune disorders. The company is dedicated to developing a platform designed to create stem cell-based therapeutic products that can treat severe blood, cardiovascular, autoimmune, and other disorders. The company is currently developing the PluriX™ 3D Bioreactor System, which is designed to create an artificial physiological environment where mesenchymal stem cells can expand in three dimensions and reproduce without the use of exogenous biologics or pharmacological products. This new method is superior to the…

ThursdayJul 10, 2008 10:39 am

Dutton Associates Featured Company: Pressure BioSciences, Inc. (PBIO)

Pressure BioSciences, Inc. (PBIO) is focused on developing products based on its proprietary pressure cycling technology (PCT) for life-sciences applications. The innovative technology utilizes hydrostatic pressure, which cycles between ambient and ultra-high levels, to rapidly and proficiently disrupt cell membranes/tissues to remove nucleic acids, proteins, and small molecules from plant and animal materials. The PCT technology has a broad range of possible applications in genomics and proteomics, in addition to drug discovery, pathogen inactivation, food safety, immunodiagnostics, and DNA sequencing. Currently, the PCT System consists of a top-of-the-line instrument and disposable PULSE sample processing tubes. Pressure BioSciences plans to develop…

ThursdayJul 10, 2008 10:11 am

Emcore Corp. (EMKR) Announces Supply Agreements Totaling $29M

The sales announcement of 2 solar photovoltaic receivers is exciting for Emcore Corp., ensuring its growth in the photovoltaic segment of its business. The sale is important for Emcore, which did very well in 2006 with a net income of $54M. In 2007, cost of revenue went up, as did SG&A, leading to a net income loss of -$58M. This sale may be its return to profitability. Emcore Solar Photovoltaic technologies convert optical light into electrical energy, enabling power generation, while Emcore fiber optics technologies convert electrical energy into optical signals, enabling high-speed communication infrastructures. Emcore builds turnkey concentrator photovoltaic…

Site Search

Company Search